{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:07:26Z","timestamp":1793639246305,"version":"4.5.1"},"reference-count":256,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,2,20]],"date-time":"2003-02-20T00:00:00Z","timestamp":1045699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The three major forms of immune\u2010mediated inflammatory myopathy are dermatomyositis (DM), polymyositis (PM), and inclusion\u2010body myositis (IBM). They each have distinctive clinical and histopathologic features that allow the clinician to reach a specific diagnosis in most cases. Magnetic resonance imaging is sometimes helpful, particularly if the diagnosis of IBM is suspected but has not been formally evaluated. Myositis\u2010specific antibodies are not helpful diagnostically but may be of prognostic value; most antibodies have low sensitivity. Muscle biopsy is mandatory to confirm the diagnosis of an inflammatory myopathy and to allow unusual varieties such as eosinophilic, granulomatous, and parasitic myositis, and macrophagic myofasciitis, to be recognized. The treatment of the inflammatory myopathies remains largely empirical and relies upon the use of corticosteroids, immunosuppressive agents, and intravenous immunoglobulin, all of which have nonselective effects on the immune system. Further controlled clinical trials are required to evaluate the relative efficacy of the available therapeutic modalities particularly in combinations, and of newer immunosuppressive agents (mycophenolate mofetil and tacrolimus) and cytokine\u2010based therapies for the treatment of resistant cases of DM, PM, and IBM. Improved understanding of the molecular mechanisms of muscle injury in the inflammatory myopathies should lead to the development of more specific forms of immunotherapy for these conditions.  Muscle Nerve 27:407\u2013425, 2003<\/jats:p>","DOI":"10.1002\/mus.10313","type":"journal-article","created":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T18:58:51Z","timestamp":1048273131000},"page":"407-425","source":"Crossref","is-referenced-by-count":173,"title":["Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects"],"prefix":"10.1002","volume":"27","author":[{"given":"Frank L.","family":"Mastaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Garlepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Zilko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,2,20]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"275","article-title":"The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases","volume":"109","author":"Adams EM","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"e_1_2_8_3_2","first-page":"352","article-title":"A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures","volume":"26","author":"Adams EM","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_8_4_2","first-page":"1300","article-title":"Elevated cancer incidence in patients with dermatomyositis: a population based study","volume":"22","author":"Airio A","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(05)70337-6"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.8.1516"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400407"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190203"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200010000-00006"},{"key":"e_1_2_8_10_2","first-page":"989","volume-title":"Disorders of voluntary muscle","author":"Argov A","year":"1994"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65680-5"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390318"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1448"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1385"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10121"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-197501000-00005"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<480::AID-MUS9>3.0.CO;2-A"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-84-1-68"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1302"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1561"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(94)90076-0"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.6.929"},{"key":"e_1_2_8_23_2","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.161.11.5943","article-title":"Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions","volume":"161","author":"Behrens L","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008093230601"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00246-4"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer\u2010assisted analysis of 153 paients with polymyositis and dermatomyositis","volume":"86","author":"Bohan A","year":"1977","journal-title":"Medicine"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92416-1"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.2.116"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-12-200106190-00008"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240107"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-3-365"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05157-0"},{"key":"e_1_2_8_34_2","first-page":"995","article-title":"Penicillamine induced polymyositis and dermatomyositis","volume":"14","author":"Carroll GJ","year":"1987","journal-title":"J Rheumatol"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.1.94"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04140.x"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90009-M"},{"key":"e_1_2_8_38_2","first-page":"1092","article-title":"Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients","volume":"21","author":"Cherin P","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(01)00194-8"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10053"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.2.326"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.7"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.1.97"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780210111"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/59.2.164"},{"key":"e_1_2_8_46_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0889-857X(21)00893-0","article-title":"Idiopathic inflammatory myopathies","volume":"16","author":"Cronin ME","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"e_1_2_8_47_2","first-page":"1225","article-title":"The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathies","volume":"16","author":"Cronin ME","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90465-6"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.6.1887"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.8.1253"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111213252107"},{"key":"e_1_2_8_52_2","first-page":"645","article-title":"Inflammatory and toxic myopathies","volume":"5","author":"Dalakas MC","year":"1992","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"e_1_2_8_53_2","first-page":"659","article-title":"Retroviruses and inflammatory myopathies in humans and primates","volume":"2","author":"Dalakas MC","year":"1993","journal-title":"Baillieres Clin Neurol"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6_Suppl_5.S37"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.55.12.1509"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.5.569"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410116"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.712"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.3.323"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100036684"},{"key":"e_1_2_8_62_2","first-page":"161","article-title":"Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease","volume":"27","author":"D'Cruz D","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199407000-00008"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/12.9.1329"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780221007"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1963.00460020045003"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.5.676"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng718"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6334364"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270402"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.6.936"},{"key":"e_1_2_8_72_2","first-page":"1335","volume-title":"Myology","author":"Engel AG","year":"1994"},{"key":"e_1_2_8_73_2","first-page":"351","volume-title":"Inclusion body myositis and myopathies","author":"Engel WK","year":"1998"},{"key":"e_1_2_8_74_2","first-page":"1340","article-title":"Resistive exercise in the rehabilitation of polymyositis\/dermatomyositis","volume":"20","author":"Escalante A","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.7.1265"},{"key":"e_1_2_8_76_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5063"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1313"},{"key":"e_1_2_8_78_2","first-page":"752","article-title":"Myositis following treatment with high\u2010dose interleukin\u20102 for malignancy","volume":"4","author":"Finger DR","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(93)90075-K"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880050112"},{"key":"e_1_2_8_81_2","first-page":"1693","article-title":"Magnetic resonance imaging in the idiopathic inflammatory myopathies","volume":"18","author":"Fraser DD","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1996.d01-10.x"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/10.3.267"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199611000-00004"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9629(15)40734-7"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1994.tb06604.x"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb03861.x"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380619"},{"key":"e_1_2_8_89_2","first-page":"177","volume-title":"Inclusion body myositis and myopathies","author":"Garlepp MJ","year":"1998"},{"key":"e_1_2_8_90_2","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestation of dermatomyositis: a series of four cases","volume":"27","author":"Gelber AC","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_8_91_2","first-page":"A321","article-title":"Intermittent, high dose, intravenous glucocorticoid (GC) treatment (Rx) is preferred to high dose oral GC administration in adult dermatomyositis (DM)","volume":"48","author":"Genge A","year":"1997","journal-title":"Neurology"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02326-5"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.9.1821"},{"key":"e_1_2_8_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5"},{"key":"e_1_2_8_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61628-5"},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118749"},{"key":"e_1_2_8_97_2","first-page":"29","article-title":"High dose intravenous immunoglobulin (IVIg) in dermatomyositis: clinical responses and effect on sIL\u20102R levels","volume":"10","author":"Gottfried I","year":"2000","journal-title":"Eur J Dermatol"},{"key":"e_1_2_8_98_2","first-page":"1921","article-title":"Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement","volume":"23","author":"Grau JM","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_8_99_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530130029013"},{"key":"e_1_2_8_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380504"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248390"},{"key":"e_1_2_8_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8"},{"key":"e_1_2_8_103_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.9.1566"},{"key":"e_1_2_8_104_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1986.tb01180.x"},{"key":"e_1_2_8_105_2","first-page":"201","article-title":"Scleromyositis a distinctive overlap syndrome","volume":"19","author":"Hausmanowa\u2010Petrusewicz I","year":"2000","journal-title":"Acta Myol"},{"key":"e_1_2_8_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92456-2"},{"issue":"1","key":"e_1_2_8_107_2","first-page":"S193","article-title":"Anti\u2010TNF blockade with Infliximab in polymyositis and dermatomyositis","volume":"43","author":"Hengstman G","year":"2000","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_108_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150070079"},{"key":"e_1_2_8_109_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.5.706"},{"key":"e_1_2_8_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(90)90026-D"},{"key":"e_1_2_8_111_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1982.tb03087.x"},{"key":"e_1_2_8_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200007)23:7<1133::AID-MUS20>3.0.CO;2-E"},{"key":"e_1_2_8_113_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199003293221301"},{"key":"e_1_2_8_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03540-6"},{"key":"e_1_2_8_115_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200011000-00005"},{"key":"e_1_2_8_116_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00007"},{"key":"e_1_2_8_117_2","first-page":"663","volume-title":"The autoimmune diseases","author":"Hollingsworth PN","year":"1998"},{"key":"e_1_2_8_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1985.tb00276.x"},{"key":"e_1_2_8_119_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199807000-00009"},{"key":"e_1_2_8_120_2","first-page":"621","article-title":"Long\u2010term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy","volume":"17","author":"Huang JL","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90148-I"},{"key":"e_1_2_8_122_2","first-page":"1380","article-title":"A functional index in myositis","volume":"23","author":"Josefson A","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_8_123_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880131010"},{"key":"e_1_2_8_124_2","first-page":"244","article-title":"The role of cytokines in polymyositis: interferon\u2010gamma induces class II and enhances class I major histocompatibility complex antigen expression on cultured human muscle cells","volume":"120","author":"Kalovidouris AE","year":"1992","journal-title":"J Lab Clin Med"},{"key":"e_1_2_8_125_2","first-page":"1698","article-title":"Synergistic cytotoxic effect of interferon\u2010gamma and tumour necrosis factor\u2010alpha on cultured human muscle cells","volume":"322","author":"Kalovidouris AE","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_126_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410707"},{"key":"e_1_2_8_127_2","first-page":"A321","article-title":"Dexamethasone (DEX) induces transcription of glutamine synthetase (GS) in human muscle in vitro: a possible explanation of steroid\u2010induced muscle atrophy (\u201csteroid myopathy\u201d)","volume":"48","author":"Koffman B","year":"1997","journal-title":"Neurology"},{"key":"e_1_2_8_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(97)00245-2"},{"key":"e_1_2_8_129_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050528"},{"key":"e_1_2_8_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(00)00144-9"},{"key":"e_1_2_8_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70263-4"},{"key":"e_1_2_8_132_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196212272672608"},{"key":"e_1_2_8_133_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410010106"},{"key":"e_1_2_8_134_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199307000-00002"},{"key":"e_1_2_8_135_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.1998.00092.x"},{"key":"e_1_2_8_136_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010000207"},{"key":"e_1_2_8_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(90)90167-L"},{"key":"e_1_2_8_138_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1994.tb01647.x"},{"key":"e_1_2_8_139_2","first-page":"476","article-title":"Anti\u2010thymocyte globulin treatment in inclusion body myositis: a randomised pilot study","volume":"9","author":"Lindberg C","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"e_1_2_8_140_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004010051041"},{"key":"e_1_2_8_141_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199111000-00002"},{"key":"e_1_2_8_142_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.1.29"},{"key":"e_1_2_8_143_2","first-page":"304","article-title":"Cyclosporin in the management of polymyositis and dermatomyositis","volume":"14","author":"Luek CJ","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_8_144_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0082-y"},{"key":"e_1_2_8_145_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.1.7"},{"key":"e_1_2_8_146_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400514"},{"key":"e_1_2_8_147_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009749709065660"},{"key":"e_1_2_8_148_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-001-0036-z"},{"issue":"1","key":"e_1_2_8_149_2","first-page":"S143","article-title":"The treatment of persistent severe idiopathic inflammatory myositis with anti\u2010TNF therapy","volume":"61","author":"Maillard SM","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_8_150_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050087"},{"issue":"7","key":"e_1_2_8_151_2","first-page":"S150","article-title":"Cyclosporin treatment in juvenile dermatomyositis: a review of 26 cases","author":"Manzur AY","year":"1998","journal-title":"Muscle Nerve"},{"key":"e_1_2_8_152_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/77.1.1019"},{"key":"e_1_2_8_153_2","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie I","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_8_154_2","first-page":"203","volume-title":"Inflammatory diseases of muscle","author":"Mastaglia FL","year":"1988"},{"key":"e_1_2_8_155_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200010000-00001"},{"key":"e_1_2_8_156_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170302"},{"key":"e_1_2_8_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00021-2"},{"key":"e_1_2_8_158_2","first-page":"453","volume-title":"Skeletal muscle pathology","author":"Mastaglia FL","year":"1992"},{"key":"e_1_2_8_159_2","first-page":"717","volume-title":"Inflammatory myopathies","author":"Mastaglia FL","year":"1993"},{"key":"e_1_2_8_160_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<651::AID-MUS1>3.0.CO;2-7"},{"key":"e_1_2_8_161_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.1.107"},{"key":"e_1_2_8_162_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-999-0008-6"},{"key":"e_1_2_8_163_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1160::AID-MUS30>3.0.CO;2-1"},{"key":"e_1_2_8_164_2","first-page":"105","article-title":"Sporadic inclusion body myositis: clinical and genetic studies","volume":"19","author":"Mastaglia FL","year":"2000","journal-title":"Acta Myol"},{"key":"e_1_2_8_165_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.8.1008"},{"key":"e_1_2_8_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(98)00188-X"},{"key":"e_1_2_8_167_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780110405"},{"key":"e_1_2_8_168_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(70)80006-7"},{"key":"e_1_2_8_169_2","first-page":"471","article-title":"Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy","volume":"10","author":"Megens\u2010de Letter M\u2010A","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"e_1_2_8_170_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197610072951506"},{"key":"e_1_2_8_171_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199606000-00014"},{"key":"e_1_2_8_172_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390521"},{"issue":"1","key":"e_1_2_8_173_2","first-page":"S53","article-title":"Randomised double blind trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy","volume":"199","author":"Miller F","year":"2002","journal-title":"J Neurol Sci"},{"key":"e_1_2_8_174_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.270.15.1846"},{"key":"e_1_2_8_175_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.11.1262"},{"key":"e_1_2_8_176_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199611000-00005"},{"key":"e_1_2_8_177_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1159::AID-MUS29>3.0.CO;2-6"},{"key":"e_1_2_8_178_2","first-page":"1454","article-title":"HTLV\u20101 and polymyositis in Jamaica","volume":"2","author":"Morgan OS","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_8_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00478-6"},{"key":"e_1_2_8_180_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050236"},{"key":"e_1_2_8_181_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.472"},{"key":"e_1_2_8_182_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-12-200106190-00031"},{"key":"e_1_2_8_183_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.33.806"},{"key":"e_1_2_8_184_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00664.x"},{"key":"e_1_2_8_185_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.2.230"},{"key":"e_1_2_8_186_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1974.00490370053007"},{"key":"e_1_2_8_187_2","first-page":"1527","article-title":"Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis: prediction and treatment with cyclosporine","volume":"26","author":"Nawata Y","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_8_188_2","first-page":"441","article-title":"Functional outcome of myositis patients: can a low\u2010dose glucocorticoid regimen achieve good functional results?","volume":"17","author":"Nzeusseu A","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_189_2","first-page":"S90","article-title":"Successful use of Infliximab in a case of refractory juvenile dermatomyositis","volume":"44","author":"Nzeusseu A","year":"2001","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_190_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200011000-00003"},{"key":"e_1_2_8_191_2","first-page":"1329","article-title":"Incidence of polymyositis\u2010dermatomyositis: a 20 year study of hospital diagnosed cases in Allegheny County, PA 1963\u20131982","volume":"17","author":"Oddis CV","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_8_192_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351014"},{"key":"e_1_2_8_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01927-3"},{"key":"e_1_2_8_194_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1994.1023"},{"key":"e_1_2_8_195_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199910000-00006"},{"key":"e_1_2_8_196_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.8.1235"},{"key":"e_1_2_8_197_2","first-page":"1198","article-title":"Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children","volume":"25","author":"Pachman LM","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_8_198_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8"},{"key":"e_1_2_8_199_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-001-0038-x"},{"key":"e_1_2_8_200_2","first-page":"1094","article-title":"Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering","volume":"26","author":"Patrick M","year":"1999","journal-title":"J Rheumatol"},{"key":"e_1_2_8_201_2","first-page":"241","article-title":"Features of polymyositis and dermatomyositis in the elderly: a case\u2010control study","volume":"18","author":"Pautas E","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_8_202_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.2.296"},{"key":"e_1_2_8_203_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1995.01890110072013"},{"key":"e_1_2_8_204_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200010000-00007"},{"key":"e_1_2_8_205_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1668::AID-MUS7>3.0.CO;2-#"},{"key":"e_1_2_8_206_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I"},{"key":"e_1_2_8_207_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1178"},{"issue":"1","key":"e_1_2_8_208_2","first-page":"S46","article-title":"The effect of resisted exercise on muscle strength in patients with myopathy","volume":"199","author":"Phillips BA","year":"2002","journal-title":"J Neurol Sci"},{"key":"e_1_2_8_209_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150200036"},{"key":"e_1_2_8_210_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199811000-00002"},{"key":"e_1_2_8_211_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/112.1.63"},{"key":"e_1_2_8_212_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(90)90024-A"},{"key":"e_1_2_8_213_2","first-page":"2436","article-title":"Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis","volume":"24","author":"Reiff A","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_8_214_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00002"},{"key":"e_1_2_8_215_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00868438"},{"key":"e_1_2_8_216_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1982.00510150027007"},{"key":"e_1_2_8_217_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/89.4.747"},{"key":"e_1_2_8_218_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.3.548"},{"key":"e_1_2_8_219_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.7.1081"},{"key":"e_1_2_8_220_2","first-page":"S193","article-title":"Etanercept is effective in the treatment of polymyositis\/dermatomyositis which is refractory to conventional therapy including steroids and other disease modifying agents","volume":"43","author":"Saadeh CK","year":"2000","journal-title":"Arthritis Rheum"},{"key":"e_1_2_8_221_2","first-page":"1385","article-title":"Inclusion body myositis: analysis of 32 cases","volume":"19","author":"Sayers ME","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_8_222_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10026"},{"key":"e_1_2_8_223_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.4.863"},{"key":"e_1_2_8_224_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.8.914"},{"key":"e_1_2_8_225_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200011000-00002"},{"key":"e_1_2_8_226_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(72)90064-2"},{"key":"e_1_2_8_227_2","first-page":"70","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman LE","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"key":"e_1_2_8_228_2","doi-asserted-by":"publisher","DOI":"10.1097\/00131402-200203000-00005"},{"key":"e_1_2_8_229_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.5.876"},{"key":"e_1_2_8_230_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.0.CO;2-C"},{"key":"e_1_2_8_231_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.130.10.1294"},{"key":"e_1_2_8_232_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6593"},{"key":"e_1_2_8_233_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.22"},{"key":"e_1_2_8_234_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1090-3798(98)80021-4"},{"key":"e_1_2_8_235_2","first-page":"668","article-title":"Classification criteria for polymyositis and dermatomyositis","volume":"22","author":"Tanimoto K","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_236_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200011000-00001"},{"key":"e_1_2_8_237_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00008"},{"key":"e_1_2_8_238_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/141.3.727"},{"key":"e_1_2_8_239_2","first-page":"285","article-title":"Selective depletion of lymphoid tissue by cyclophosphamide","volume":"10","author":"Turk L","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_8_240_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022060-00003"},{"key":"e_1_2_8_241_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007789"},{"key":"e_1_2_8_242_2","doi-asserted-by":"publisher","DOI":"10.1080\/030097400750001897"},{"key":"e_1_2_8_243_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199611000-00008"},{"key":"e_1_2_8_244_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X"},{"key":"e_1_2_8_245_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1982.tb06865.x"},{"key":"e_1_2_8_246_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050005"},{"key":"e_1_2_8_247_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199405000-00004"},{"key":"e_1_2_8_248_2","first-page":"101","article-title":"Dermatomyositis sine myositis: association with malignancy","volume":"23","author":"Whitmore SE","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_8_249_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.2.196"},{"key":"e_1_2_8_250_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(00)90212-0"},{"key":"e_1_2_8_251_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.5.384"},{"key":"e_1_2_8_252_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.12.1542"},{"key":"e_1_2_8_253_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200011000-00004"},{"key":"e_1_2_8_254_2","first-page":"1855","article-title":"The overall and temporal association of cancer with polymyositis and dermatomyositis","volume":"21","author":"Zantos D","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_8_255_2","first-page":"1424","article-title":"Cyclosporin A therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases","volume":"23","author":"Zeller V","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_8_256_2","first-page":"107","volume-title":"Inflammatory diseases of muscle","author":"Zilko PJ","year":"1988"},{"key":"e_1_2_8_257_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-199707040-00003"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.10313","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.10313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:12:08Z","timestamp":1700266328000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.10313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,20]]},"references-count":256,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1002\/mus.10313"],"URL":"https:\/\/doi.org\/10.1002\/mus.10313","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"value":"0148-639X","type":"print"},{"value":"1097-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,20]]}}}